A synopsis of Lenvatinib

Anniepery28 Jan, 2022Health

Lenvatinib is a tyrosine kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). It is an anti-tumour medicine, and it is used in treating patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. The medicine is supplied in 10 mg and 4 mg capsules for oral administration. Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumour growth, and cancer progression. Lenvatinib price is affordable in India, and this medicine is readily available with multiple generic medicine suppliers. The Indian Pharma is one of the licensed suppliers, supplying drugs globally for more than 7 years.

Recent Profiles

Emily Jones Real Estate

Emily Jones Real Estate

View Profile

Tim88

Tim88

View Profile

Fletcher Byrd

Fletcher Byrd

View Profile

Haahr Holmes

Haahr Holmes

View Profile

Rodriguez Gunn

Rodriguez Gunn

View Profile

High Levin

High Levin

View Profile

Richard Foley

Richard Foley

View Profile

accsmaster

Accsmaster

View Profile

Jacobson Mcleod

Jacobson Mcleod

View Profile